Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
about
Bisphosphonates in multiple myeloma: a network meta-analysisBisphosphonates in multiple myelomaUse of intravenous bisphosphonates in older women with breast cancerThe use of bisphosphonates in patients with breast cancer.Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer.New therapeutic agents for the treatment of bone diseases.Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectThe safety of zoledronic acid.Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate.Bisphosphonates in multiple myeloma: an updated network meta-analysis.
P2860
Q24197839-53B16F28-C371-412E-BF43-937D32BFDAD6Q24236776-F236EA76-2616-4F6C-A763-FA342AAB6C01Q33666930-FDF5FA41-C2E4-4AA5-BB86-772E7646C486Q35039488-66AA81F9-C4B7-4A6E-9404-C1C26FC78D7BQ35208717-5745BCFC-A3B6-4D82-9234-9D7964F32066Q36161232-3DD6976F-5F49-4B4D-BE25-24DAE7014D40Q36678173-4120E7EF-3517-4682-BEA0-9BA332C43F07Q36811542-8143B1D0-19A0-490B-AA00-D187DCAB2718Q36823566-6849B8DD-2BCB-4CF9-A3AD-9CCA77703A67Q37402732-5FB1AD60-6B56-4C4A-9C7E-C3E9FE1B8629Q41497465-CF04DF9E-28FD-4965-B43F-6C3F5AB06B9DQ42465607-3E28D2B0-DEFF-4252-BC20-DE9D6C85C96BQ47290135-E981A863-176F-443C-902D-E3C2AF166E4D
P2860
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@ast
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@en
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@nl
type
label
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@ast
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@en
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@nl
prefLabel
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@ast
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@en
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@nl
P2093
P1476
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
@en
P2093
F J Esteva
G Hortobagyi
P304
P356
10.1200/JCO.2001.19.14.3434
P407
P577
2001-07-01T00:00:00Z